.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Martin F. Fromm

Erlangen / DE

Friedrich-Alexander-Universität Erlangen-Nürnberg

Chair

13/03/2024
17:00 – 18:30
Poster
Drug transport/delivery and metabolism
Poster Self-Study 6

Further involvements

13/03/2024
14:45 – 15:00 10 Min. 5 Min.
Short talk
16
Untargeted metabolomics for diagnosis and treatment of adrenocortical tumors: Screening for novel biomarkers in urine
CNS / endocrine pharmacology
13/03/2024
Poster Self-Study
P127
Characterization of a Photoswitchable GLUT1 Inhibitor
Ion channels and membrane transporters
13/03/2024
Poster Self-Study
P099
Identification of the aromatic amino acids L-tryptophan, L-tyrosine and L-phenylalanine as substrates of the organic anion transporting polypeptide (OATP) 3A1 using LC-MS based metabolomics
Ion channels and membrane transporters
13/03/2024
Poster Self-Study
P075
In vitro analysis of new putative biomarkers for OCT2/MATE-mediated renal drug-drug interactions
Drug transport/delivery and metabolism
14/03/2024
Poster Self-Study
P166
Pseudo-worsening of renal function due to inhibition of transporter-mediated renal secretion of creatinine: Overview of perpetrating drugs and insights from US, UK and German Summaries of Product Characteristics (SmPCs)
Pharmacoepidemiology and drug safety
14/03/2024
Poster Self-Study
P173
Medication safety in paediatric oncology: Benefit of integrating a clinical pharmacist into an interprofessional treatment team
Pharmacoepidemiology and drug safety
14/03/2024
Poster Self-Study
P172
Are medication errors in oral antitumor therapy comparable between data from the randomized AMBORA trial and clinical routine?
Pharmacoepidemiology and drug safety